The Leaking Source and the Unmonitored Worker
A university research laboratory uses a 50 mCi americium-241 source in a sealed-source irradiator. The laboratory's radiation safety officer (RSO) conducts a quarterly leak test by wiping the source and counting the wipe with a survey meter. The RSO's survey meter is calibrated for gamma and beta, but not for alpha. The wipe count shows no activity above background. Six months later, a researcher who regularly uses the irradiator is found to have an elevated body burden of americium-241 during a routine bioassay. The RSO reviews the leak test records and realizes the survey meter cannot detect alpha contamination from a leaking source. The researcher had not been included in the bioassay program because the source was considered sealed and intact. The RSO must now respond to the contamination event and the potential overexposure.
1. Identify the primary failure in the leak test procedure and explain how it allowed the contamination to go undetected.
Read the worked answer
The primary failure is the use of a survey meter that cannot detect alpha radiation. Americium-241 is an alpha emitter, and a leaking source would release alpha contamination. The RSO used a gamma/beta meter, which is insensitive to alpha particles, so the wipe test could not detect any removable alpha contamination. Even if the wipe had collected alpha activity, the meter would not register it. Additionally, the RSO did not perform a direct measurement of the wipe with an alpha-sensitive detector or send it for liquid scintillation counting. The false negative leak test led to the belief that the source was intact, so no bioassay program was implemented for the researcher. This failure allowed the researcher to inhale or ingest alpha contamination over six months, resulting in the elevated body burden.
2. What corrective actions should the RSO take to prevent recurrence and to address the regulatory reporting requirements?
Read the worked answer
Corrective actions: (1) Immediately suspend use of the irradiator and perform a proper leak test using an alpha-sensitive detector or liquid scintillation counting. (2) Decontaminate the area and the source, and verify the source integrity. (3) Implement a bioassay program for all individuals who work with or near alpha-emitting sources, including baseline and periodic bioassays. (4) Revise the leak test procedure to require appropriate instrumentation and trained personnel. (5) Retrain staff on alpha detection and contamination control. (6) Report the event to the regulator as required by 10 CFR 30.50 or equivalent, including the failure of the leak test and the potential overexposure. (7) Notify the affected individual and provide medical follow-up. (8) Conduct a root-cause analysis and document corrective actions. The RSO should also review all other sealed sources to ensure leak test methods are adequate.